Priorix 1000 Ccid50 (Rubella Virus Vaccine Live Attenuated (Wistar Ra27/3 Strain) KIT) 1000 CCID50

Priorix 1000 CCID50 is a rubella virus vaccine designed for immunization. This live attenuated vaccine helps protect against rubella, a contagious viral infection.

Strength

1000 CCID50

Pack Size

0.5 ML DOSE X 10

Manufacturer / TM Owner

GLAXOSMITHKLINE INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Priorix 1000 CCID50 is used for the prevention of rubella, a viral infection that can cause serious complications, especially in pregnant women. This vaccine is typically administered as part of a routine immunization schedule to help build immunity against rubella. What is Priorix 1000 CCID50 used for? It is primarily used to prevent rubella infection and its associated complications.

Side Effects

Common effects of Priorix 1000 CCID50 may include mild fever, soreness at the injection site, and general discomfort. These effects are usually temporary and resolve on their own. Some individuals may experience more severe reactions, but these are rare.

Precautions & Warnings

Priorix 1000 CCID50 should be handled with care and stored as directed. It is important to inform healthcare providers about any allergies or medical conditions before administration. This vaccine should not be used by individuals who are pregnant or have a weakened immune system unless advised by a healthcare professional.

Avoid Interactions

Priorix 1000 CCID50 may interact with certain medications, including immunosuppressants and other live vaccines. It is important to discuss all current medications with a healthcare provider before receiving this vaccine. Alcohol and other substances may also affect the body's response to the vaccine.

Frequently Asked Questions

Priorix 1000 CCID50 is used to prevent rubella infection and its associated complications.

Priorix 1000 CCID50 is administered intramuscularly, typically in the upper arm.

Common side effects may include mild fever, soreness at the injection site, and general discomfort.

Priorix 1000 CCID50 should not be used during pregnancy unless advised by a healthcare professional.

If you experience severe reactions, seek medical attention immediately.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.